52 Week High Alert for Skivisible Inc. (SKVI) as Kintari Gets Closer to Launch

52 Week High Alert for Skivisible Inc. (SKVI) as Kintari Gets Closer to Launch

Everything is coming together for Skinvisible Inc. (OTCQB: SKVI) as it nears its official Kintari Launch. We seen the stock more than double in recent weeks from its low point. The stock’s momentum is catapulting the share price to nearly triple now.

Today’s high is $0.0849

Let’s put that in perspective:

  • That’s 13.96% up today over yesterday’s close.
  • That’s 112.25% over the low this month.
  • That’s 121.67% over the low from recent weeks.

What is Kintari?

The answer from the most recent press release from SKVI: KINTARI_LOGO-350w

The Kintari product portfolio consists of “Youth Renewed” (YR) anti-aging products to help fight the signs of aging. These products have been developed using proven anti-aging ingredients with scientific evidence of their effectiveness at reducing the look of fine lines and wrinkles resulting in youthful looking skin. These potent ingredients are powered by our patented Invisicare® technology, providing consumers with unique, effective skincare benefits which cannot be duplicated.

Kintari has an exclusive license to patented Invisicare products from its parent company Skinvisible Pharmaceuticals, Inc., a science-based research and development company. Skinvisible continues to build its worldwide patent portfolio while seeking licensees for its prescription and over-the-counter dermatology products.

 

Here is that release:

Skinvisible’s Subsidiary Kintari Announces Network Marketing Expert Dean Aldridge as Master Distributor
Kintari Launching Patented Skin Care Product Line

 

Las Vegas, NV– October 29, 2014 – Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) – through its wholly owned subsidiary Kintari International Inc., makers of patented “Youth Renewed” skin care products – is pleased to announce the selection of R. Dean Aldridge in the key role of Master Distributor. Dean will spearhead distributor expansion and development globally.

“We are very pleased to have Dean Aldridge, a world class marketer and sales leader, as our Master Distributor for Kintari,” said Terry Howlett, President of Kintari. “The Master Distributor plays a crucial role in the upward trajectory of the number of distributors that join Kintari and the sales they produce. Dean has exactly the skills and experience to make Kintari a huge success.” He added, “Dean has proven his skills over the past fifteen years in the network marketing industry. He is a multiple award winner and has climbed to the highest level of every company he has been associated with. Dean is often referred to as one of the top recruiters as well as one of the best relationship builders our industry has seen. His expertise has taken him to the top echelons of financial rewards and is touted as one of network marketing’s most distinguished international leaders.”

 

READ THE FULL RELEASE HERE

 

John Pentony now represents Skinvisible Pharmaceuticals, Inc. as its investor relations coordinator internally. In the past John Pentony’s company was hired for the distribution of news and blogs about Skinvisible. John Pentony and any family member or associated companies do not hold shares, warrants or other positions in Skinvisible stock. In years past John Pentony’s company (Pentony Enterprise LLC / “PE”) has received a total of eight thousand in cash payments. In 2009 PE was compensated 500k shares of restricted stock. John Pentony has signed a contract to as investor relations for Skinvisible, and will be paid up to eleven thousand dollars during the next twelve months should the contract go for twelve months as expected.

Logo Header Menu